Skip to content
The Nexus
DossierENTITY

AI foundation models

Coverage of AI foundation models in the Nexus archive.

Earliest in view: May 27 · 00:30 UTCMost recent: Jun 3 · 20:45 UTC
Co-mentioned in this coverage
Insilico Medicineorganization2Human Longevityorganization2Hong Kongplace2Alnylamorganization1Inceptive Nucleicsorganization1Jakob Uszkoreitperson1RNAi therapeuticstopic1Googleorganization1United Statesplace1Cancertopic1Global longevity markettopic1cancertopic1global longevity markettopic1USplace1
Recent coverage
  • BUSINESSJun 3 · 20:45 UTCSTAT NEWS
    STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics

    Alnylam partners with Inceptive Nucleics to develop AI foundation models for RNAi therapeutics. The three-year collaboration is worth up to $2 billion, with $30 million upfront in cash and equity. Jakob Uszkoreit, former Google researcher, co-founded Inceptive Nucleics after contributing to foundational AI research.

  • HEALTHMay 27 · 00:30 UTCSCMP WORLD
    Insilico teams up with US firm to build AI models predicting disease decades ahead

    Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage advancements in AI and the growing $5.3 trillion global longevity market driven by aging populations.

  • HEALTHMay 27 · 00:30 UTCSCMP CHINA
    Insilico teams up with US firm to build AI models predicting disease decades ahead

    Insilico Medicine, a Hong Kong-listed AI drug-discovery company, has partnered with US-based Human Longevity to develop large-scale AI foundation models capable of predicting diseases like cancer decades before symptoms appear. The collaboration aims to leverage the growing global longevity market, valued at $5.3 trillion.